Multifunctional gold nanoparticles for improved diagnostic and therapeutic applications: a review

NRS Sibuyi, KL Moabelo, AO Fadaka, S Meyer… - Nanoscale Research …, 2021 - Springer
The medical properties of metals have been explored for centuries in traditional medicine for
the treatment of infections and diseases and still practiced to date. Platinum-based drugs are …

Recurrent respiratory papillomatosis: current and future perspectives

M Carifi, D Napolitano, M Morandi… - … and clinical risk …, 2015 - Taylor & Francis
Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive
tract caused by infection with human papillomavirus, the disease process is unpredictable …

Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles

R Mendes, P Pedrosa, JC Lima, AR Fernandes… - Scientific Reports, 2017 - nature.com
Photothermal Therapy (PTT) impact in cancer therapy has been increasing due to the
enhanced photothermal capabilities of a new generation of nanoscale photothermal agents …

Current and future management of recurrent respiratory papillomatosis

R Ivancic, H Iqbal, B deSilva, Q Pan… - Laryngoscope …, 2018 - Wiley Online Library
Objectives Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory
tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV) …

Systemic bevacizumab for recurrent respiratory papillomatosis: a national survey

SR Best, M Mohr, KB Zur - The Laryngoscope, 2017 - Wiley Online Library
Objectives/Hypothesis Aggressive laryngeal, tracheal, and pulmonary papilloma is an
extremely challenging clinical problem without proven treatment options. A recent German …

Recurrent respiratory papillomatosis: a 2020 perspective

JJ Benedict, CS Derkay - Laryngoscope investigative …, 2021 - Wiley Online Library
Objective Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a
rare but challenging benign airway neoplasm. In recent years there has been significant …

Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - The …, 2021 - Wiley Online Library
Objectives/Hypothesis The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis

M Mohr, C Schliemann, C Biermann… - Oncology …, 2014 - spandidos-publications.com
Recurrent respiratory papillomatosis (RRP) is a primary benign disease, which is
characterized by papillomatous growth in the respiratory tract. Malignant transformation …

Use of adjuvant intralesional bevacizumab for aggressive respiratory papillomatosis in children

DJ Rogers, S Ojha, R Maurer… - … Otolaryngology–Head & …, 2013 - jamanetwork.com
Importance Juvenile recurrent respiratory papillomatosis (RRP) can be an aggressive
disease process necessitating frequent trips to the operating room with multiple anesthetics …

Benign central airway obstruction

CL Oberg, VK Holden… - Seminars in respiratory …, 2018 - thieme-connect.com
Benign central airway obstruction (CAO) is responsible for significant morbidity due to
dyspnea and impaired quality of life. While iatrogenic causes, including stenosis after …